Life Sciences: IP/Patent Litigation
California
2 years ranked
Provided by Morrison Foerster
Karen Potter is a partner in Morrison Foerster’s Life Sciences Patent group. Her practice focuses on patent preparation, prosecution, and strategic counseling for start‑up, emerging, and established life sciences and biotechnology companies. She advises clients in the development and management of comprehensive patent portfolios that match their scientific and business objectives. Karen also helps identify and evaluate patentability, ensure freedom to operate, and perform due diligence review of patent portfolios for clients, including investor-side and target-side due diligence.
Building on her technical expertise in cellular and molecular biology and immunology, Karen has experience managing and developing patent portfolios in the areas of cell and gene therapies, including T-cell therapies, Natural Killer cell-based therapies, stem cell therapies and gene-based therapies; protein therapeutics such as immunotherapies, including antibody and protein-based therapies; virus therapies; companion diagnostics; and diagnostic assays and bioassays.
Karen has 18 years of experience in global patent portfolio development and strategy. She works closely with clients to counsel them on all matters of patent strategy and prosecution and is adept at quickly understanding complex technologies to implement patent filing strategies. She manages and mentors a team of scientific analysts, patent agents, and associates in establishing and building life sciences patent portfolios. Representative clients include Alpine Immune Sciences, Applied Biomedical Science Institute, Aspen Neuroscience, Bristol Myers Squibb and its subsidiaries Juno Therapeutics and Celgene, Indapta Therapeutics, Inhibrx, Rakuten Medical, Sana Biotechnology, Tune Therapeutics, and Turnstone Biologics.
Before entering the patent field, Karen was a postdoctoral fellow at the La Jolla Institute for Allergy and Immunology, Department of Molecular Immunology, in the laboratory of Dr. Carl F. Ware. During her doctorate studies, she worked in the laboratory of the late Dr. Jo Rae Wright who served as an invaluable mentor and supporter. The results of her research have been published in peer-reviewed scientific journals, and she has presented her results at national scientific meetings.
She received her J.D. from California Western School of Law, Ph.D. in cellular and molecular biology from Duke University, and B.S. in molecular biology from the University of California, San Diego.
Provided by Chambers
Karen Potter assists with patent preparation, strategy and prosecution for both well-established and emerging biotechnology and life sciences companies.
Karen Potter is experienced in advising life sciences and biotechnology companies on protecting discoveries and building patent portfolios. She is particularly skilled in developing patent portfolios in the areas of cell and gene therapies.
Provided by Chambers
Karen's knowledge base is really valuable. She is also conscientious and open to feedback.
Karen is an excellent IP practitioner.
Karen is an excellent lawyer and scientist, as well as a wonderful person who comprehends the complex challenges faced by startups in the life sciences space.
Karen Potter is brilliant. She is technically astute, on top of the case law and always asks insightful questions. I would always want her in my corner.
Karen Potter is highly responsive, pays close attention to detail, and is well prepared for client meetings. She is extremely knowledgeable about biology-related disciplines and curates well-trained, client-specific teams aligned according to expertise. Work products by Karen and her team are consistently of high quality.
Karen Potter is technically skilled, with a deep scientific background and strong knowledge of our business. She is very responsive and able to anticipate needs.
Chambers is the leading data and intelligence partner for the legal sector.